FDA grants Fast Track designation to nintedanib for SSc-ILD
Boehringer Ingelheim has announced that the FDA has granted Fast Track designation to nintedanib for the treatment of SSc-ILD...
List view / Grid view
Boehringer Ingelheim has announced that the FDA has granted Fast Track designation to nintedanib for the treatment of SSc-ILD...
A compound that mimics a naturally occurring hormone that regulates appetite may help people who have obesity but not diabetes to lose weight...
A new birth control pill for men appears to be safe when used daily for a month, with hormone responses consistent with effective contraception...
Researchers are calling for medicinal cannabis to be properly established in our modern medical arsenal...
An innovative use of a known drug is showing promise as an effective treatment for preventing postoperative nausea and vomiting (PONV)....
A new class of experimental drugs reduces hot flushes in menopausal women by almost three-quarters in just three days...
Researchers have developed a fluorescing nanoparticle capable of finding tumours, lighting up upon arrival and being activated with light to generate heat to destroy the cancer cells...
In this series, our Science Editor Dr. Zara Kassam, interviews influential decision-makers and female leaders within the pharmaceutical industry, as they discuss their careers, the challenges they’ve faced and the importance of breaking through self-imposed barriers...
Human tissue samples linked by microfluidic channels replicate interactions of multiple organs.
A landmark £40million has been awarded to the UK Dementia Research Institute, via the Medical Research Council, for a new iconic hub building at University College London...
Medical researchers point to a promising route for designing an effective vaccine for the respiratory syncytial virus...
Researchers have found that incorporating imaging technologies more precisely can predict heart attack risk...
An immunotherapy drug embedded in a slow-release hydrogel appears to be highly effective at killing cancer cells...
Scientists reveal that this dangerous drug could suppress nerve cell death...
As part of EPR’s Women in Pharma series, Elaine Chiquette Head of Science at Gelesis, Inc, talks to Science Editor Dr Zara Kassam about positive challenges, embracing responsibilities and being committed to your goals…